HK1222332A1 - 治療肝臟疾病的方法 - Google Patents
治療肝臟疾病的方法Info
- Publication number
- HK1222332A1 HK1222332A1 HK16110571.8A HK16110571A HK1222332A1 HK 1222332 A1 HK1222332 A1 HK 1222332A1 HK 16110571 A HK16110571 A HK 16110571A HK 1222332 A1 HK1222332 A1 HK 1222332A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- inhibiting
- liver disease
- liver
- disease
- Prior art date
Links
- 230000002401 inhibitory effect Effects 0.000 title 1
- 208000019423 liver disease Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201462044593P | 2014-09-02 | 2014-09-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1222332A1 true HK1222332A1 (zh) | 2017-06-30 |
Family
ID=54106121
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16110571.8A HK1222332A1 (zh) | 2014-09-02 | 2016-09-06 | 治療肝臟疾病的方法 |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP2992885A3 (zh) |
CN (1) | CN105380949A (zh) |
HK (1) | HK1222332A1 (zh) |
TW (1) | TW201613600A (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3241552A1 (en) * | 2016-05-02 | 2017-11-08 | Jansfat Biotechnology Co., Ltd. | Compositions and methods for lipid metabolism disorder |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5358941A (en) | 1992-12-02 | 1994-10-25 | Merck & Co., Inc. | Dry mix formulation for bisphosphonic acids with lactose |
GB0202254D0 (en) * | 2002-01-31 | 2002-03-20 | Pfizer Ltd | Prevention of scarring |
WO2008124505A2 (en) * | 2007-04-05 | 2008-10-16 | Ironwood Pharmaceuticals,Inc. | Soluble guanylate cyclase (sgc) modulators for treatment of lipid related disorders |
PE20100156A1 (es) * | 2008-06-03 | 2010-02-23 | Boehringer Ingelheim Int | Tratamiento de nafld |
TWI462739B (zh) * | 2010-11-02 | 2014-12-01 | Univ Kaohsiung Medical | Sildenafil-同族物四級銨哌嗪鹽類之製備及醫療用途 |
TWI542350B (zh) * | 2011-09-06 | 2016-07-21 | 高雄醫學大學 | Kmup複合銨鹽類及高分子聚合物之改善高脂血及體重失衡療效 |
MX2016011063A (es) * | 2014-02-27 | 2016-11-30 | Nusirt Sciences Inc | Composiciones y metodos para la reduccion o prevencion de esteatosis hepatica. |
-
2015
- 2015-08-25 TW TW104127774A patent/TW201613600A/zh unknown
- 2015-08-25 EP EP15182424.0A patent/EP2992885A3/en not_active Withdrawn
- 2015-08-25 CN CN201510527647.4A patent/CN105380949A/zh active Pending
-
2016
- 2016-09-06 HK HK16110571.8A patent/HK1222332A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
TW201613600A (en) | 2016-04-16 |
EP2992885A3 (en) | 2016-05-18 |
CN105380949A (zh) | 2016-03-09 |
EP2992885A2 (en) | 2016-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201406151D0 (en) | Method | |
GB201406155D0 (en) | Method | |
GB201413240D0 (en) | Method | |
SG11201609350XA (en) | Methods for inhibiting necroptosis | |
IL249868A0 (en) | method | |
HUE053058T2 (hu) | Eljárás állatok helyének meghatározására | |
PL3196196T3 (pl) | Sposób wytwarzania kalcobutrolu | |
PL3094519T3 (pl) | Lampa, jak również sposób wykorzystania takiej lampy | |
ZA201608777B (en) | Method for preparing methyl mercaptan | |
HK1244039A1 (zh) | 打樁方法 | |
PL3169844T3 (pl) | Sposób zapobiegania tworzeniu się kamienia kotłowego | |
GB201403470D0 (en) | Method | |
GB201402036D0 (en) | Method for determination of the status of a disease | |
GB201420832D0 (en) | Location method | |
PL3201391T3 (pl) | Sposób przetwarzania słomy | |
GB2538030B (en) | Up-drawing casting method | |
HK1222332A1 (zh) | 治療肝臟疾病的方法 | |
GB2528750B (en) | Method for integrally forming a sole with hobnails | |
GB201522624D0 (en) | A method | |
GB201521650D0 (en) | A method | |
ZA201604816B (en) | Method for producing a component | |
PL3137689T3 (pl) | Sposób wykonania ściany ze stabilizowanej ziemi | |
ZA201502004B (en) | A method for tracking a vehicle | |
GB201420242D0 (en) | A cross-contamination prevention method | |
GB201407948D0 (en) | Method |